| . |
| . |
| . |
| . |
| Offering a convenient, relaxed, and safe environment for the administration of intravenous medications. |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| . |
| Clinical Research |
| Also: Schering-Plough OPTIMIST Schering-Plough REALITY Merck ICE |
 |
| |
 |
| |
 |
| Clinical Trials |
| BioClin is currently conducting the following clinical research studies: Abbott DE013 A prospective multi-centre randomised, double- blind, active comparator-controlled, parallel- groups study comparing the fully human monoclonal anti-TNFalpha antibody D2E7 given every second week with methotrexate given weekly and the combination of D2E7 and methotrexate administered over 2 years in patients with early rheumatoid arthritis. • Patient Recruitment: CLOSED Abbott DE019 A multicentre randomized double blind placebo- controlled Phase III study of the human anti-TNF antibody D2E7 administered as subcutaneous injections to patients with active Rheumatoid Arthritis currently receiving treatment treated with MTX. • Patient Recruitment: CLOSED |
| Proud to be a Canadian Owned & Operated Company |
| BioClin Health Care .... Caring to make a difference |
| Copyright 2012 BioClin Health Care Inc / Legal Notice |